Partial
Partially Aligned
Patient Risk:
Low
Summary
The label supports that Viagra contains sildenafil and is supplied in 25 mg, 50 mg, and 100 mg strengths. It does not explain “AGV” or support the claims about its meaning, use, or variation across markets.
Category Scores
Accurate Statements
Sildenafil is the active ingredient in Viagra.
Section 11 identifies sildenafil citrate as the active ingredient and describes Viagra tablets as equivalent to the stated amounts of sildenafil.
Sildenafil tablets may be labeled in strengths such as 25 mg, 50 mg, or 100 mg.
The label states that Viagra is supplied in strengths equivalent to 25 mg, 50 mg, or 100 mg of sildenafil. This supports those strengths for Viagra, not necessarily for all sildenafil tablets.
Unsupported Statements
“AGV” is commonly used as a brand or product code/suffix, not a medical abbreviation.
The supplied label does not mention “AGV” or describe its use.
In “Viagra AGV,” “AGV” typically identifies a specific manufacturer, distributor, or local formulation or packaging variant of sildenafil.
The label identifies Pfizer and describes Viagra markings and packaging, but does not mention or explain “AGV.”
“AGV” does not name a component of the medication.
The label lists ingredients but does not establish what “AGV” means in the referenced product name.
“AGV” is used as a label to distinguish one version of a sildenafil product from others.
The label describes other product markings and identifiers, but does not mention “AGV.”
The meaning of “AGV” can differ across markets.
The supplied label does not discuss “AGV” or differences in meaning across markets.
Many “Viagra” variants and online listings refer to sildenafil tablets with different brand or product codes.
The label lists Viagra product markings and NDCs but does not address online listings or this broader claim about variants.
Sildenafil tablets may be labeled in strengths such as 25 mg, 50 mg, or 100 mg.
The label supports these strengths for Viagra, but does not establish the available strengths of sildenafil tablets generally.
Contradictions
Important Omissions
The supplied label does not identify or define “AGV,” so its meaning in “Viagra AGV” cannot be established from this label.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The claims do not give dosing instructions or advise treatment. The unsupported statements concern product identification and could cause confusion, but no direct conflict with the supplied label is present.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
The label does not explain “AGV,” but several claims assert what it means or how it is used.
Suggested Improvement
State that the supplied FDA label does not define “AGV,” and limit the strength claim to Viagra tablets.